Age and Late Recurrence in Young Patients With ER–Positive, ERBB2-Negative Breast Cancer

Young patients with breast cancer with estrogen receptor (ER)-positive, ERBB2-negative tumors have a poor prognosis. Understanding factors influencing late recurrence is crucial for improving management and outcomes.